HeLa Symposium Tackles Immunotherapy in Cancer
Named for the late Henrietta Lacks, MSM hosted its 21st annual HeLa event
Morehouse School of Medicine (MSM) hosted its 21st Annual HeLa Women's Health Symposium
on Sept. 23, 2016, highlighting the benefits of precision medicine through the life,
legacy and contribution of Henrietta Lacks.
Titled “Precision Medicine & Health Equity: Immunotherapy in Cancer,” the symposium focused on immunotherapies, which are one of the most important cancer research advances in decades.
MSM’s event addressed research, clinical and health advocacy through presentations and took into account the importance of achieving health equity through advancements and innovative approaches in cancer and beyond.
The annual event is named in honor Henrietta Lacks, an African-American woman who
died at the age of 31 in 1951 from cervical cancer and was the source of HeLa cells--known
as the first breakthrough in growing human cells outside the body. Some of Lacks’
family members also attended the event.
About Morehouse School of Medicine (MSM)
Founded in 1975, MSM is among the nation's leading educators of primary care physicians
and was recognized by Annals of Internal Medicine in 2011 as the top institution in
the first study of U.S. medical schools for our social mission based on our production
of primary care physicians, training of underrepresented minority doctors and placement
of doctors practicing in underserved communities. Our faculty and alumni are noted
for excellence in teaching, research and public policy, as well as exceptional patient
care.
Morehouse School of Medicine is accredited by the Southern Association of Colleges and Schools Commission on Colleges to award doctorate and master degrees. For more information, please visit www.msm.edu.
